BioLife Solutions, Inc. Increase (Decrease) in Accrued Taxes Payable
BioLife Solutions, Inc. (BLFS) reported Increase (Decrease) in Accrued Taxes Payable of -$187.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedTaxesPayable · last filed 2026-08-06
- BioLife Solutions, Inc. increase (decrease) in accrued taxes payable for the quarter ending 2026-06-30 was -$39.00K.
- BioLife Solutions, Inc. increase (decrease) in accrued taxes payable for the quarter ending 2026-03-31 was -$148.00K.
- BioLife Solutions, Inc. increase (decrease) in accrued taxes payable for the quarter ending 2025-12-31 was -$1.39M.
- BioLife Solutions, Inc. increase (decrease) in accrued taxes payable for the quarter ending 2025-09-30 was $105.00K.
- BioLife Solutions, Inc. increase (decrease) in accrued taxes payable for fiscal 2025 was -$1.91M.
- BioLife Solutions, Inc. increase (decrease) in accrued taxes payable for fiscal 2024 was -$973.00K, a 174.22% decline from fiscal 2023.
- BioLife Solutions, Inc. increase (decrease) in accrued taxes payable for fiscal 2023 was $1.31M, a 14.09% decline from fiscal 2022.
- BioLife Solutions, Inc. increase (decrease) in accrued taxes payable for fiscal 2022 was $1.53M, a 8.07% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Taxes Payable 3 month | Increase (Decrease) in Accrued Taxes Payable 6 month | Increase (Decrease) in Accrued Taxes Payable 9 month | Increase (Decrease) in Accrued Taxes Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$187.00K 10-Q · filed 2026-08-06 | -$1.57M derived: sum of 3 quarters · filed 2026-08-06 | -$1.47M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$148.00K 10-Q · filed 2026-05-07 | -$1.53M derived: sum of 2 quarters · filed 2026-05-07 | -$1.43M derived: sum of 3 quarters · filed 2026-05-07 | -$1.73M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.28M derived: sum of 2 quarters · filed 2026-02-26 | -$1.58M derived: sum of 3 quarters · filed 2026-08-06 | -$1.91M 10-K · filed 2026-02-26 |
| 2025-09-30 | $105.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$193.00K derived: sum of 2 quarters · filed 2026-08-06 | -$520.00K 10-Q · filed 2025-11-06 | -$604.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$298.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$625.00K 10-Q · filed 2026-08-06 | -$709.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.21M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$327.00K 10-Q · filed 2026-05-07 | -$411.00K derived: sum of 2 quarters · filed 2026-05-07 | -$912.00K derived: sum of 3 quarters · filed 2026-05-07 | -$1.32M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$585.00K derived: sum of 2 quarters · filed 2026-02-26 | -$993.00K derived: sum of 3 quarters · filed 2026-02-26 | -$973.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | -$501.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$909.00K derived: sum of 2 quarters · filed 2025-11-06 | -$889.00K 10-Q · filed 2025-11-06 | -$908.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$408.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$388.00K 10-Q · filed 2025-08-07 | -$407.00K derived: sum of 3 quarters · filed 2026-02-26 | $5.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $20.00K 10-Q · filed 2025-05-08 | $1.00K derived: sum of 2 quarters · filed 2026-02-26 | $413.00K derived: sum of 3 quarters · filed 2026-02-26 | $821.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $393.00K derived: sum of 2 quarters · filed 2026-02-26 | $801.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.31M 10-K · filed 2026-02-26 |
| 2023-09-30 | $412.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $820.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.33M 10-Q · filed 2024-11-12 | $1.33M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $408.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $918.00K 10-Q · filed 2024-08-09 | $918.00K derived: sum of 3 quarters · filed 2025-03-03 | $846.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $510.00K 10-Q · filed 2024-05-10 | $510.00K derived: sum of 2 quarters · filed 2025-03-03 | $438.00K derived: sum of 3 quarters · filed 2025-03-03 | $493.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$72.00K derived: sum of 2 quarters · filed 2025-03-03 | -$17.00K derived: sum of 3 quarters · filed 2025-03-03 | $1.53M 10-K · filed 2025-03-03 |
| 2022-09-30 | -$72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$17.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.53M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $55.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.60M 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $1.54M 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $1.41M 10-K · filed 2024-02-29 | |||
| 2020-12-31 | $759.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |